MYFEMBREE

Peak

relugolix, estradiol hemihydrate, and norethindrone acetate

NDAORALTABLET
Approved
May 2021
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

Gonadotropin Releasing Hormone Receptor Antagonists

Pharmacologic Class:

Gonadotropin Releasing Hormone Receptor Antagonist

Loss of Exclusivity

LOE Date
Nov 5, 2042
203 months away
Patent Expiry
Nov 5, 2042
Exclusivity Expiry
Jan 27, 2026

Patent Records (5)

Patent #ExpiryTypeUse Code
8058280
Jan 28, 2026Expired
SubstanceProduct
7300935
Jan 28, 2029
Substance
12325714
Sep 27, 2033
SubstanceProduct
11795178
Sep 27, 2033
SubstanceProduct
11033551
Sep 29, 2037
U-3129